10-Q: NewHydrogen Q2 Loss Widens Amid R&D Push, Cash Dips
Quarterly Report
NewHydrogen, Inc. reported a widened net loss and decreased cash for Q2 2025, signaling increased operational burn as it advances its green hydrogen technology.
Summary
- NewHydrogen, Inc. reported a net loss of $1,099,798 for the six months ended June 30, 2025, compared to a net loss of $909,746 for the same period in 2024, representing a 20.9% increase in loss.
- The company generated no revenue during both the current and prior periods.
- Total operating expenses increased to $1,100,103 for the six months ended June 30, 2025, up from $910,380 in the prior year.
- Research and development expenses rose by $71,507 to $249,385, driven by increased outside research fees and consultant costs.
- Selling and marketing expenses increased by $55,371 to $200,571, primarily due to an increase in service providers.
- General and administrative expenses increased by $63,258 to $648,506, mainly due to higher professional fees and non-cash stock compensation.
- Cash balance decreased significantly to $1,100,906 as of June 30, 2025, from $2,104,521 at December 31, 2024.
- Net cash used in operating activities increased to $1,003,615 for the six months ended June 30, 2025, compared to $824,205 in the prior period.
- Working capital decreased to $1,150,677 as of June 30, 2025, from $2,102,308 at December 31, 2024.
- The accumulated deficit grew to $179,042,345 as of June 30, 2025.
- The company entered into an equity financing agreement with GHS Investments for up to $3,000,000 over 24 months, and has already issued shares for proceeds of $298,769 (July 17, 2025) and $145,604 (August 6, 2025) under this agreement.
Sentiment
Score: 3
Explanation: The company is in a critical development phase with no revenue, increasing losses, and a rapidly declining cash balance. The 'going concern' warning and reliance on future, uncertain financing indicate significant financial instability, outweighing the potential of its technology.
Positives
- The company is actively developing its ThermoLoop technology, which aims to produce green hydrogen using heat instead of expensive electricity, potentially lowering production costs significantly.
- NewHydrogen continues its research collaboration with a world-class team at UC Santa Barbara.
- Secured an equity financing agreement with GHS Investments for up to $3 million, providing a potential source of future capital.
- Management believes current cash flows and anticipated funding from existing and new investors will enable the company to meet its obligations for the next six months.
Negatives
- The company has not generated any revenue to date, indicating it is still in a pre-commercialization stage.
- Net loss increased by 20.9% year-over-year for the six months ended June 30, 2025.
- Operating expenses have significantly increased across all categories (selling & marketing, general & administrative, research & development).
- Cash balance declined by nearly 50% from year-end 2024, and net cash used in operating activities increased.
- Working capital has substantially decreased, indicating a weakening liquidity position.
- The company's independent auditors expressed substantial doubt about its ability to continue as a going concern without additional capital.
- The accumulated deficit has grown to over $179 million, reflecting significant historical losses.
Risks
- The company's ability to continue as a going concern is dependent on achieving profitable operations and securing additional equity or debt financing.
- There is no assurance that future financing will be available or, if available, that it will be on terms satisfactory to the company.
- Future equity financing may cause substantial dilution for existing stockholders.
- Debt financing, if obtained, may contain undue restrictions on the company's operations.
- The company holds cash balances in excess of FDIC limits ($850,906 as of June 30, 2025), exposing it to credit risk.
- Performance milestones for 100,000,000 stock options granted to employees are considered unlikely to be met in the next 12 months due to the company's current market capitalization and low average daily trading volume.
Future Outlook
The company plans to utilize its current cash balances to maintain the existing ThermoLoop technology development program at UC Santa Barbara. Management believes current cash and investment balances will be sufficient to support development activity and general and administrative expenses for the next nine months. Additional cash resources are estimated to be required during 2025, with increased expenses not expected until early 2026 when prototyping efforts related to its thermochemical water splitting technology ramp up. The company's long-term goal is to help usher in the green hydrogen economy, which Goldman Sachs estimated to have a future market value of $12 trillion.
Management Comments
- Management believes this funding will continue from its current investors and from new investors.
- Management believes the existing shareholders, and the prospective new investors will provide the additional cash needed to meet the Company's obligations as they become due and will allow the development of its core business operations.
- Management believes the Company's present cash flows will enable it to meet its obligations for six months from the date of these financial statements.
- Management will continue to assess its operational needs and seek additional financing as needed to fund its operations.
- Management believes the probability of satisfying vesting conditions for 100,000,000 performance-based stock options is less than ten (10) percent during the next 12 months, based on the current market cap of less than $5,000,000 and average trading stock volume of less than $5,000 per day.
Industry Context
NewHydrogen, Inc. operates in the clean energy technology sector, specifically focusing on green hydrogen production. The company aims to disrupt the traditional hydrogen market, which is largely dependent on fossil fuels, by developing a novel thermochemical water splitting process. This technology seeks to overcome the high cost of green hydrogen produced via electrolysis (where electricity accounts for 73% of the cost) by directly utilizing inexpensive heat sources like concentrated solar, geothermal, nuclear reactors, and industrial waste heat. This positions the company within the rapidly growing green hydrogen economy, which has been projected by Goldman Sachs to reach a future market value of $12 trillion.
Comparison to Industry Standards
- As a development-stage company with no revenue, NewHydrogen, Inc. lacks direct operational comparable companies or projects with established revenue streams and profitability.
- The company's focus on thermochemical water splitting using heat is a distinct approach compared to the more common electrolysis method for green hydrogen production, aiming to address the high electricity cost (73% of green hydrogen cost) that is a significant challenge for current industry players.
- While the filing does not provide specific comparable financial metrics, the company's increasing net loss and cash burn are typical of early-stage technology development companies, but the 'going concern' warning highlights a more severe liquidity challenge compared to well-capitalized industry peers.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure Controls and Procedures Evaluation | The Chief Executive Officer and acting Chief Financial Officer concluded that the company's disclosure controls and procedures were effective as of June 30, 2025. | 2025-06-30 | Indicates management's confidence in the effectiveness of internal controls for financial reporting and disclosure, which is positive for governance. |
Legal Proceedings
- As of June 30, 2025, there were no legal proceedings against the company.
Stakeholder Impact
- Shareholders face significant dilution risk from ongoing and future equity financing activities.
- Shareholders are exposed to substantial risk of capital loss due to the company's pre-revenue status, increasing losses, and the 'going concern' warning.
- Employees and consultants, particularly those with stock options, have their compensation and future tied to the company's ability to secure funding and achieve commercial success.
- Creditors face increased risk due to the company's precarious financial position and reliance on future financing to meet obligations.
Next Steps
- Utilize current cash balances to maintain the existing ThermoLoop technology development program at UC Santa Barbara.
- Seek additional financing as needed to fund operations and meet obligations.
- Ramp up prototyping efforts related to thermochemical water splitting technology in early 2026.
Key Dates
| Date | Description |
|---|---|
| 2021-02-18 | Company granted 450,000,000 stock options to employees for services. |
| 2021-03-18 | First installment of 8,333,333 shares vested for 400,000,000 options and 1,388,889 shares vested for 50,000,000 options granted on February 18, 2021. |
| 2021-09-29 | Company amended the exercise price of 450,000,000 stock options to $0.028 per share. |
| 2022-03-01 | Company issued 5,000,000 common stock purchase warrants through a securities purchase agreement. |
| 2022-03-15 | Company granted 5,000,000 stock options to a consultant for advisory services. |
| 2022-04-12 | Company cancelled 450,000,000 stock options dated February 18, 2021, and concurrently granted 450,000,000 new options to employees. |
| 2023-03-11 | One employee separated from the company, leading to the cancellation of 50,000,000 options. |
| 2023-03-20 | Company granted 50,000,000 shares of stock options pursuant to its 2022 Equity Incentive Plan. |
| 2023-05-09 | Company granted 5,000,000 shares of stock options to a consultant. |
| 2023-05-30 | Company amended the consultant agreement dated March 15, 2022. |
| 2023-06-01 | Vesting period began for 5,000,000 options granted on May 9, 2023. |
| 2023-06-15 | Company granted 100,000,000 shares of stock options to two employees. |
| 2023-08-01 | Company entered into a research agreement with the Regents of the University of California. |
| 2023-09-19 | 8,333,333 shares vested and became exercisable from the 50,000,000 options granted on March 20, 2023. |
| 2023-11-30 | 833,360 options vested from the 5,000,000 options granted on May 9, 2023. |
| 2024-12-09 | Company entered into an agreement with a consultant for advisory service in developing green hydrogen technology, granting 2,500,000 common stock options. |
| 2024-12-17 | Company entered into an agreement with a consultant to provide laboratory support for green hydrogen technology development. |
| 2025-01-01 | Vesting began for 2,500,000 common stock options granted on December 9, 2024. |
| 2025-03-12 | The 5,000,000 stock options granted on March 15, 2022, vested. |
| 2025-03-15 | Termination date for the consultant agreement amended on May 30, 2023. |
| 2025-04-15 | Company entered into an agreement with a consultant to serve as Chief Technology Officer. |
| 2025-05-01 | Company entered into an agreement with a consultant to perform research and granted 2,500,000 common stock options. |
| 2025-05-01 | Company entered into an agreement with the Regents of the University of California to obtain an exclusivity option on a jointly filed patent for 12 months. |
| 2025-05-02 | Company issued 803,536 common shares for equity financing cost and entered into an equity financing agreement with GHS Investments. |
| 2025-06-30 | End of the current quarterly reporting period. |
| 2025-07-17 | Company issued 11,616,962 free trading shares to GHS Investments, receiving $298,769. |
| 2025-08-06 | Company issued 4,770,259 free trading shares to GHS Investments, receiving $145,604. |
| 2025-08-12 | Number of common stock shares issued and outstanding was 717,020,010. |
| 2025-08-13 | Date of signing the Quarterly Report on Form 10-Q. |
| 2027-12-01 | Expiration date for 2,500,000 options granted on December 9, 2024. |
| 2029-03-01 | Termination date for 5,000,000 common stock purchase warrants issued on March 1, 2022. |
| 2030-03-19 | Expiration date for 50,000,000 stock options granted on March 20, 2023. |
| 2030-06-15 | Expiration date for 100,000,000 stock options granted on June 15, 2023. |
| 2032-03-15 | Expiration date for 5,000,000 stock options granted on March 15, 2022. |
| 2033-05-31 | Expiration date for 5,000,000 stock options granted on May 9, 2023. |
| 2035-05-01 | Expiration date for 2,500,000 options granted on May 1, 2025. |
Recommendation
strong sellThe company is pre-revenue with a rapidly increasing net loss and cash burn. The explicit 'going concern' warning from auditors, coupled with a significant accumulated deficit and reliance on uncertain future financing, indicates extreme financial risk. While the technology has long-term potential, the immediate financial outlook is highly precarious, making it a high-risk investment with a strong likelihood of further capital erosion and dilution.
Keywords
Green Hydrogen, Clean Energy Technology, ThermoLoop, Water Splitting, Thermochemical, Hydrogen Production, Renewable Energy, SEC Filing, 10-Q, Development Stage, Liquidity, Going Concern
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.